Systematic review of technology-mediated peer support interventions in paediatric type 1 diabetes care

Reena Titoria1, Andrea Fung2, Tricia S Tang3

  • 1Provincial Health Services Authority, Vancouver, British Columbia, Canada.

Insights

Technology-mediated peer support shows potential for improving pediatric type 1 diabetes care. While not consistently improving psychosocial outcomes, some studies noted reduced hypoglycemia, warranting further research.

Area of Science:

  • Pediatric Endocrinology
  • Digital Health
  • Behavioral Medicine

Background:

  • Peer support is increasingly recognized in diabetes management.
  • Technology-mediated peer support for pediatric type 1 diabetes is under-researched.
  • Interventions aim to support children, caregivers, and healthcare providers.

Conclusions:

  • Technology-mediated peer support may offer benefits for diabetes care and outcomes.
  • Further high-quality research is needed to address diverse populations and intervention sustainability.
  • Well-designed studies are essential to optimize technology-driven peer support in pediatric diabetes.
Abstract

Related Concept Videos

Self-Help Support Groups01:28

Self-Help Support Groups

Self-help support groups are voluntary, community-based organizations that provide a platform for individuals with shared concerns to exchange support, insights, and practical strategies for coping with life challenges. Typically led by group members or paraprofessionals, these groups form a cornerstone of mental health care, especially in reaching populations that are underserved by traditional healthcare systems.
Accessibility and Cost-Effectiveness
One of the primary strengths of self-help...
59
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
213